(Q39852216)

15 September 2017

title

A novel FRET-based biosensor for the measurement of BCR-ABL activity and its response to drugs in living cells (English)

1 reference

15 September 2017

A Novel FRET-Based Biosensor for the Measurement of BCR-ABL Activity and Its Response to Drugs in Living Cells (English)

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

13 June 2024

0 references

1

Tatsuaki Mizutani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670950

13 June 2024

author name string

Takeshi Kondo

2

1 reference

15 September 2017

Stephanie Darmanin

3

1 reference

15 September 2017

Masumi Tsuda

4

1 reference

15 September 2017

Shinya Tanaka

5

1 reference

15 September 2017

Minoru Tobiume

6

1 reference

15 September 2017

Masahiro Asaka

7

1 reference

15 September 2017

Yusuke Ohba

8

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

full work available at URL

15 September 2017

https://aacrjournals.org/clincancerres/article-pdf/16/15/3964/1991479/3964.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670950

http://clincancerres.aacrjournals.org/cgi/content/abstract/16/15/3964

13 June 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670950

https://aacrjournals.org/clincancerres/article-pdf/16/15/3964/1991479/3964.pdf

13 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

13 June 2024

published in

Clinical Cancer Research

1 reference

15 September 2017

volume

16

1 reference

15 September 2017

issue

15

1 reference

15 September 2017

page(s)

3964-3975

1 reference

15 September 2017

cites work

Targeted cancer therapy

1

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

The molecular genetics of Philadelphia chromosome-positive leukemias

13 June 2024

2

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

13 June 2024

3

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Chromosomal localization of human cellular homologues of two viral oncogenes.

13 June 2024

4

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

13 June 2024

5

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Translation of the Philadelphia chromosome into therapy for CML.

13 June 2024

6

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Chronic myelogenous leukemia

13 June 2024

7

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

13 June 2024

8

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Survival advantage from imatinib compared with the combination interferon- plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials

13 June 2024

9

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Crk family adaptors-signalling complex formation and biological roles

13 June 2024

10

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML.

13 June 2024

14

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling.

13 June 2024

15

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Mechanism of the spatio-temporal regulation of Ras and Rap1.

13 June 2024

16

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry.

13 June 2024

17

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Statistics notes: the normal distribution

13 June 2024

18

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

A pair of fluorescent resonance energy transfer-based probes for tyrosine phosphorylation of the CrkII adaptor protein in vivo.

13 June 2024

19

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications

13 June 2024

20

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Activity of Rho-family GTPases during cell division as visualized with FRET-based probes

13 June 2024

21

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells

13 June 2024

22

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

13 June 2024

23

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Overriding imatinib resistance with a novel ABL kinase inhibitor

13 June 2024

24

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.

13 June 2024

25

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants

13 June 2024

26

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants

13 June 2024

27

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

13 June 2024

28

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

13 June 2024

30

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

13 June 2024

Chronic myeloid leukemia

32

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

13 June 2024

33

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization

13 June 2024

34

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

13 June 2024

36

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.

13 June 2024

37

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

13 June 2024

38

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Measurement of in vivo BCR-ABL kinase inhibition to monitor imatinib-induced target blockade and predict response in chronic myeloid leukemia

13 June 2024

39

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Optimization of methods for the detection of BCR-ABL activity in Philadelphia-positive cells

13 June 2024

40

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Rapid detection of phosphotyrosine proteins by flow cytometric analysis in Bcr-Abl-positive cells

13 June 2024

41

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Analysis of total phosphotyrosine levels in CD34+ cells from CML patients to predict the response to imatinib mesylate treatment

13 June 2024

42

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2.

13 June 2024

43

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance

13 June 2024

44

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors

13 June 2024

45

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

13 June 2024

46

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Getting to the stem of chronic myeloid leukaemia

13 June 2024

47

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Tumour stem cells and drug resistance

13 June 2024

48

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

13 June 2024

49

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-0548

13 June 2024

Identifiers

1 reference

release_z5dlvmd7rne33npfzwsj7windi

15 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z5dlvmd7rne33npfzwsj7windi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference